Lisata Therapeutics Inc LSTA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/28/24 EDT
3.18quote price arrow up+0.06 (+1.92%)
Volume
201
Close
3.12UNCH (UNCH)
Volume
13,997
52 week range
1.95 - 4.53
Loading...
  • Open3.27
  • Day High3.27
  • Day Low3.10
  • Prev Close3.26
  • 52 Week High4.53
  • 52 Week High Date06/14/23
  • 52 Week Low1.95
  • 52 Week Low Date09/15/23

Key Stats

  • Market Cap25.919M
  • Shares Out8.31M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta1.05
  • YTD % Change14.29

KEY STATS

  • Open3.27
  • Day High3.27
  • Day Low3.10
  • Prev Close3.26
  • 52 Week High4.53
  • 52 Week High Date06/14/23
  • 52 Week Low1.95
  • 52 Week Low Date09/15/23
  • Market Cap25.919M
  • Shares Out8.31M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta1.05
  • YTD % Change14.29

RATIOS/PROFITABILITY

  • EPS (TTM)-2.58
  • P/E (TTM)-1.21
  • Fwd P/E (NTM)-1.00
  • EBITDA (TTM)-25.536M
  • ROE (TTM)-36.33%
  • Revenue (TTM)-
  • Gross Margin (TTM)9.15%
  • Net Margin (TTM)-179.78%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/07/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Lisata Therapeutics Inc

 

Profile

MORE
Lisata Therapeutics, Inc. is a clinical-stage pharmaceutical company. The Company is engaged in the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other major diseases. Its lead investigational product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered anti-cancer drugs to penetrate solid tumors. LSTA1 actuates this active transport system in a tumor-specific...
Gregory Brown M.D.
Independent Chairman of the Board
David Mazzo Ph.D.
Chief Executive Officer, Director
Kristen Buck M.D.
Executive Vice President - Research & Development, Chief Medical Officer
Address
110 Allen Road, Second Floor
Basking Ridge, NJ
07920
United States

Top Peers

SYMBOLLASTCHG%CHG
UBX
UNITY Biotechnology Inc
1.64UNCHUNCH
ABIO
ARCA Biopharma Inc
1.78UNCHUNCH
FBRX
Forte Biosciences Inc
0.6962UNCHUNCH
BCLI
Brainstorm Cell Therapeutics Inc
0.5647UNCHUNCH
LABP
Landos Biopharma Inc
21.50UNCHUNCH